Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aptose Biosciences Inc. | Sr VP and CFO | Employee Stock Option (Right to Buy) | 55K | Feb 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APTO | Aptose Biosciences Inc. | Feb 5, 2024 | 1 | $0 | 4 | Feb 7, 2024 | Sr VP and CFO |
APTO | Aptose Biosciences Inc. | Jan 19, 2023 | 2 | $0 | 4 | Jan 23, 2023 | SR VP & Chief Fin. Officer |
APTO | Aptose Biosciences Inc. | Sep 19, 2022 | 1 | $6.78K | 4 | Sep 21, 2022 | SR VP & Chief Fin. Officer |
APTO | Aptose Biosciences Inc. | Jun 27, 2022 | 1 | $0 | 4 | Jun 28, 2022 | SR VP & Chief Fin. Officer |
APTO | Aptose Biosciences Inc. | Jun 27, 2022 | 0 | $0 | 3 | Jun 28, 2022 | SR VP & Chief Fin. Officer |